Participant flow

Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies · Source last updated 2026-03-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Orca-T administered after myeloablative conditioning followed by single-agent tacrolimus

   id

   FG000

   title

   Orca-T

2. description

   Unmanipulated allograft from peripheral blood of a matched donor after myeloablative conditioning followed by tacrolimus and methotrexate

   id

   FG001

   title

   Standard of Care

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         1

      type

      Adverse Event

   2. reasons

      1. group Id

         FG000

         num Subjects

         3

      2. group Id

         FG001

         num Subjects

         9

      type

      Death

   3. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      type

      Lost to Follow-up

   4. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         4

      type

      Physician Decision

   5. reasons

      1. group Id

         FG000

         num Subjects

         3

      2. group Id

         FG001

         num Subjects

         5

      type

      Withdrawal by Subject

   6. reasons

      1. group Id

         FG000

         num Subjects

         14

      2. group Id

         FG001

         num Subjects

         9

      type

      Progression/Relapse

   7. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      type

      Received Standard of Care

   8. reasons

      1. group Id

         FG000

         num Subjects

         70

      2. group Id

         FG001

         num Subjects

         64

      type

      Ongoing

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         93

      2. group Id

         FG001

         num Subjects

         94

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         88

      2. group Id

         FG001

         num Subjects

         94

      type

      Participants Treated

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         2

      type

      COMPLETED

   4. achievements

      1. group Id

         FG000

         num Subjects

         93

      2. group Id

         FG001

         num Subjects

         92

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

187 participants were randomized to treatment from 19 study centers, of which 182 participants were treated

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice